期刊论文详细信息
Influenza and Other Respiratory Viruses
2009 pandemic Influenza A (H1N1): clinical and laboratory characteristics in pediatric and adult patients and in patients with pulmonary involvement
Ing-Kit Lee1  Jien-Wei Liu1  Lin Wang2  Kuender D. Yang3  Chung-Chen Li2 
[1] Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan;Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan;Department of Pediatrics, Show Chwan Memorial Hospital, Changhua, Taiwan
关键词: adults;    children;    consolidation;    interstitial infiltrates;    lung involvement;    oseltamivir;    pandemic influenza A (H1N1);   
DOI  :  10.1111/j.1750-2659.2012.00410.x
来源: Wiley
PDF
【 摘 要 】

Abstract

Please cite this paper as: Lee and Liu et al. (2012) 2009 pandemic Influenza A (H1N1): clinical and laboratory characteristics in pediatric and adult patients and in patients with pulmonary involvement. Influenza and Other Respiratory Viruses 6(601), e152–e161.

Background  To better understand clinical and laboratory characteristics in children, adults, and patients with lung involvement suffering 2009 pandemic influenza A (H1N1).

Methods  A total of 442 patients with 2009 pandemic influenza A (H1N1) were retrospectively analyzed.

Results  Comparing to their adult counterpart (n = 55), pediatric patients (n = 387) had significantly higher frequencies of fever, rhinorrhea, cough, sore throat, nausea/vomiting, and longer length of fever; lower frequencies of chest pain and dyspnea; higher incidence of lymphopenia; and lower incidence of elevated serum C-reactive protein. Among the 227 patients with radiographs available, lung involvement was found in 19 (8·4%) (52·6% consolidation and 47·4% interstitial infiltrations), including 18 children and one adult. One child with lung consolidation died of multiorgan failure. Significant findings in patients with lung involvement included predominant young age (≤10 years), prolonged fever, and delayed oseltamivir therapy (≥48 hours after onset of illness); higher frequencies of dyspnea, nausea/vomiting, and altered consciousness; and higher incidences of leukopenia, elevated serum creative kinase, and lactic dehydrogenase.

Conclusions  Among patients with 2009 pandemic influenza A (H1N1), we found significant difference in clinical manifestations between children and adults, and significant differences in clinical and laboratory manifestations between patients with lung involvement and those without. On the basis of data from this study and the existing literature, early treatment with oseltamivir is recommended for patients with 2009 pandemic influenza A (H1N1), regardless of age.

【 授权许可】

Unknown   
© 2012 Blackwell Publishing Ltd

【 预 览 】
附件列表
Files Size Format View
RO202107150012940ZK.pdf 146KB PDF download
  文献评价指标  
  下载次数:6次 浏览次数:1次